Medicoeconomic analysis of lobectomy using thoracoscopy versus thoracotomy for lung cancer: a study protocol for a multicentre randomised controlled trial (Lungsco01)

Pierre-Benoit Pagès, Halim Abou Hanna, Anne-Claire Bertaux, Ludwig Serge Serge Aho, Pierre Magdaleinat, Jean-Marc Baste, Marc Filaire, Richard de Latour, Jalal Assouad, François Tronc, Christophe Jayle, Jérome Mouroux, Pascal-Alexandre Thomas, Pierre-Emmanuel Falcoz, Charles-Henri Marty-Ané, Alain Bernard, Pierre-Benoit Pagès, Halim Abou Hanna, Anne-Claire Bertaux, Ludwig Serge Serge Aho, Pierre Magdaleinat, Jean-Marc Baste, Marc Filaire, Richard de Latour, Jalal Assouad, François Tronc, Christophe Jayle, Jérome Mouroux, Pascal-Alexandre Thomas, Pierre-Emmanuel Falcoz, Charles-Henri Marty-Ané, Alain Bernard

Abstract

Introduction: In the last decade, video-assisted thoracoscopic surgery (VATS) lobectomy for non-small cell lung cancer (NSCLC) has had a major effect on thoracic surgery. Retrospective series have reported benefits of VATS when compared with open thoracotomy in terms of postoperative pain, postoperative complications and length of hospital stay. However, no large randomised control trial has been conducted to assess the reality of the potential benefits of VATS lobectomy or its medicoeconomic impact.

Methods and analysis: The French National Institute of Health funded Lungsco01 to determine whether VATS for lobectomy is superior to open thoracotomy for the treatment of NSCLC in terms of economic cost to society. This trial will also include an analysis of postoperative outcomes, the length of hospital stay, the quality of life, long-term survival and locoregional recurrence. The study design is a two-arm parallel randomised controlled trial comparing VATS lobectomy with lobectomy using thoracotomy for the treatment of NSCLC. Patients will be eligible if they have proven or suspected lung cancer which could be treated by lobectomy. Patients will be randomised via an independent service. All patients will be monitored according to standard thoracic surgical practices. All patients will be evaluated at day 1, day 30, month 3, month 6, month 12 and then every year for 2 years thereafter. The recruitment target is 600 patients.

Ethics and dissemination: The protocol has been approved by the French National Research Ethics Committee (CPP Est I: 09/06/2015) and the French Medicines Agency (09/06/2015). Results will be presented at national and international meetings and conferences and published in peer-reviewed journals.

Trial registration number: NCT02502318.

Keywords: Cardiothoracic surgery; HEALTH ECONOMICS; Respiratory tract tumours; STATISTICS & RESEARCH METHODS.

Conflict of interest statement

Competing interests: Jean-Marc Baste reports consulting and lecture fees from Covidien and consulting fee from Ethicon. The other authors have nothing to disclose with regard to commercial support.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Flow chart of the protocol.

References

    1. Binder-Foucard F, Bossard N, Delafosse P, et al. . French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique 2014;62:95–108.10.1016/j.respe.2013.11.073
    1. Howington JA, Blum MG, Chang AC, et al. . Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer. Chest 2013(143):e278S–313.
    1. Paul S, Altorki NK, Sheng S, et al. . Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010;139:366–78.10.1016/j.jtcvs.2009.08.026
    1. Thomas PA, Berbis J, Falcoz PE, et al. . EPITHOR Group. National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status. Eur J Cardiothorac Surg 2014;45:652–9.10.1093/ejcts/ezt452
    1. Stéphan F, Boucheseiche S, Hollande J, et al. . Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest 2000;118:1263–70.
    1. Pagès PB, Delpy JP, Orsini B, et al. . Propensity score analysis comparing videothoracoscopic lobectomy with Thoracotomy: a French Nationwide Study. Ann Thorac Surg 2016;101:1370–8.10.1016/j.athoracsur.2015.10.105
    1. Bendixen M, Jørgensen OD, Kronborg C, et al. . Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung Cancer: a randomised controlled trial. Lancet Oncol 2016;17:836–44.10.1016/S1470-2045(16)00173-X
    1. Whitson BA, Groth SS, Duval SJ, et al. . Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy.Ann Thorac Surg 2008. 88 2008 16
    1. Yan TD, Black D, Bannon PG, et al. . Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung Cancer. J Clin Oncol 2009;27:2553–62.10.1200/JCO.2008.18.2733
    1. Li Z, Liu H, Li L. Video-assisted thoracoscopic surgery versus open lobectomy for stage I lung cancer: A meta-analysis of long-term outcomes. Exp Ther Med 2012;3:886–92.10.3892/etm.2012.485
    1. Zhang Z, Zhang Y, Feng H, et al. . Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung Cancer? A systematic review and meta-analysis. Eur J Cardiothorac Surg 2013;44:407–14.10.1093/ejcts/ezt015
    1. Cao C, Manganas C, Ang SC, et al. . A meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomy. Ann Cardiothorac Surg 2012;1:16–23.10.3978/j.issn.2225-319X.2012.04.18
    1. Taioli E, Lee DS, Lesser M, et al. . Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis. Eur J Cardiothorac Surg 2013;44:591–7.10.1093/ejcts/ezt051
    1. Chen FF, Zhang D, Wang YL, et al. . Video-assisted thoracoscopic surgery lobectomy versus open lobectomy in patients with clinical stage Ⅰ non-small cell lung cancer: a meta-analysis. Eur J Surg Oncol 2013;39:957–63.10.1016/j.ejso.2013.06.016
    1. Cai YX, Fu XN, Xu QZ, et al. . Thoracoscopic lobectomy versus open lobectomy in stage I non-small cell lung Cancer: a meta-analysis. PLoS One 2013;8:e8236610.1371/journal.pone.0082366
    1. Kirby TJ, Mack MJ, Landreneau RJ, et al. . Lobectomy--video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg 1995;109:997–1002.10.1016/S0022-5223(95)70326-8
    1. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 2000;24:27–31.10.1007/s002689910006
    1. Palade E, Passlick B, Osei-Agyemang T, et al. . Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial. European Journal of Cardio-Thoracic Surgery 2013;44:244–9.10.1093/ejcts/ezs668
    1. Shigemura N, Akashi A, Nakagiri T, et al. . Complete versus assisted thoracoscopic approach: a prospective randomized trial comparing a variety of video-assisted thoracoscopic lobectomy techniques. Surg Endosc 2004;18:1492–7.10.1007/s00464-003-8252-4
    1. Craig SR, Leaver HA, Yap PL, et al. . Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 2001;20:455–63.10.1016/S1010-7940(01)00841-7
    1. Paul S, Isaacs AJ, Treasure T, et al. . Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database. BMJ 2014;349:g5575.10.1136/bmj.g5575
    1. Heinze G, Jüni P. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J 2011;32:1704–8.10.1093/eurheartj/ehr031
    1. Cho S, Do YW, Lee EB. Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung Cancer. Surg Endosc 2011;25:1054–61.10.1007/s00464-010-1315-4
    1. Swanson SJ, Meyers BF, Gunnarsson CL, et al. . Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multiinstitutional database analysis. Ann Thorac Surg 2012;93:1027–32.10.1016/j.athoracsur.2011.06.007
    1. Casali G, Walker WS. Video-assisted thoracic surgery lobectomy: can we afford it? Eur J Cardiothorac Surg 2009;35:423–8.10.1016/j.ejcts.2008.11.008
    1. Farjah F, Backhus LM, Varghese TK, et al. . Ninety-day costs of video-assisted thoracic surgery versus open lobectomy for lung cancer. Ann Thorac Surg 2014;98:191–6.10.1016/j.athoracsur.2014.03.024
    1. Park BJ, Flores RM. Cost comparison of robotic, video-assisted thoracic surgery and thoracotomy approaches to pulmonary lobectomy. Thorac Surg Clin 2008;18:297–300.10.1016/j.thorsurg.2008.05.003
    1. Deen SA, Wilson JL, Wilshire CL, et al. . Defining the cost of care for lobectomy and segmentectomy: a comparison of open, video-assisted thoracoscopic, and robotic approaches. Ann Thorac Surg 2014;97:1000–7 10.1016/j.athoracsur.2013.11.021
    1. Lim E. VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a multi-centre randomised controlled trial with an internal pilot . 2015. .
    1. Rusch VW, Crowley J, Giroux DJ, et al. . International Staging Committee Cancer Research and Biostatistics Observers to the Committee Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603–12.10.1097/JTO.0b013e31807ec803
    1. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy Amst Neth 1990;16:199–208.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren